Insider Transactions in Q2 2023 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2023
|
Andrew A. F. Hack |
BUY
Grant, award, or other acquisition
|
Direct |
14,467
+50.0%
|
-
|
|
Jun 08
2023
|
Lawrence M Alleva Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,467
+50.0%
|
-
|
|
Jun 08
2023
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,467
+2.53%
|
-
|
|
Jun 08
2023
|
Martin H. Huber Jr. President, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,467
+50.0%
|
-
|
|
Jun 08
2023
|
Kristen Hege Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,467
+50.0%
|
-
|
|
Jun 08
2023
|
Allene M. Diaz Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,467
+50.0%
|
-
|
|
Jun 08
2023
|
Willard H Dere Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,467
+44.78%
|
-
|
|
Apr 27
2023
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,944
-16.25%
|
$11,832
$3.89 P/Share
|
|
Apr 26
2023
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,250
+35.31%
|
-
|
|
Apr 03
2023
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,866
+0.89%
|
-
|
|
Apr 03
2023
|
Willard H Dere Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,375
+50.0%
|
-
|